Natco Furthers Chinese Interest With Xinjiang Pharmaceutical Alliance

Indian Firm ‘Active In China, But Through Partnerships,’ First Approval In 2022

 
• By Dean Rudge
  
Chinese flag
Natco had previously fallen short in a Chinese tender • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business